false
0000912061
0000912061
2024-10-30
2024-10-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
|
October 30, 2024
|
|
Date of Report (Date of earliest event reported)
|
| |
NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-36849
|
59-2705336
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
| |
|
|
Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong
(Address of principal executive offices, including zip code)
+852-3107-0800
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| |
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| |
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| |
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| |
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
| |
☐ |
Emerging growth company
|
| |
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
Securities registered pursuant to Section 12(b) of the Exchange Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.001 per share
|
NHTC
|
The NASDAQ Stock Market LLC
|
Item 2.02 Results of Operations and Financial Condition.
On October 30, 2024, Natural Health Trends Corp. issued an earnings release announcing its results for the quarter ended September 30, 2024. The press release is attached hereto as exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 30, 2024
|
|
NATURAL HEALTH TRENDS CORP.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Timothy S. Davidson
|
|
|
|
|
Timothy S. Davidson
|
|
|
|
|
Senior Vice President and Chief Financial Officer
|
|
Exhibit 99.1
Natural Health Trends Reports Third Quarter 2024 Financial Results
| |
– |
Total net sales increased sequentially and year-over-year during the third quarter of 2024 |
| |
– |
Improved operating bottom line for three consecutive quarters |
| |
– |
Generated cash flows from operations before 2017 Tax Act installment of $514,000 during the first nine months of 2024 |
| |
– |
Declared a quarterly cash dividend of $0.20 per share |
HONG KONG – October 30, 2024 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended September 30, 2024.
Third Quarter 2024 Financial Highlights
| |
•
|
Revenue of $10.7 million increased 1% compared to $10.6 million in the third quarter of 2023.
|
| |
•
|
Net income was $35,000, or breakeven per diluted share, compared to $172,000, or $0.02 per diluted share, in the third quarter of 2023. The decrease was attributable to lower interest income and higher effective tax rate as compared to the third quarter of 2023.
|
| |
1
|
Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.
|
Year-to-Date 2024 Financial Highlights
| |
•
|
Revenue of $32.1 million decreased 3% compared to $33.0 million in the first nine months of 2023.
|
| |
•
|
Operating loss improved to $878,000 compared to $1.4 million in the first nine months of 2023.
|
| |
•
|
Net income was $396,000, or $0.03 per diluted share, compared to $210,000, or $0.02 per diluted share, in the first nine months of 2023.
|
Management Commentary
"Consumer spending in our main market continues to be weak. However, we still managed to achieve sequential growth in net sales, as well as a year-over-year improvement in the third quarter. While the pace of growth is not where we’d like it to be, our customers and leaders continue to demonstrate strong engagement, and we are working closely with them to navigate these changing times with trainings, product roadshows and new products to help drive growth and expand their customer base," commented Chris Sharng, President of Natural Health Trends Corp.
Mr. Sharng continued, “Our ability to adapt, adjust programs, and fine-tune our plans has been instrumental in supporting our customer base while also acting in the best interests of our shareholders. We are maintaining attentive focus on cost control, including expense management, inventory, and product optimization, to ensure the company remains positioned for future success.”
Balance Sheet and Cash Flow
| |
•
|
Net cash used in operating activities was $3.5 million in the first nine months of 2024 compared to $4.2 million in the first nine months of 2023. Before tax installment payments, the liability of which arises from the 2017 U.S. Tax Cuts and Jobs Act (the “Tax Act”), cash provided by operating activities was $514,000 in the first nine months 2024, versus cash used in operating activities of $1.2 million in the comparable period a year ago. Of the total Tax Act liability of $20.2 million, $15.1 million has been paid to date.
|
| |
•
|
Total cash, cash equivalents and marketable securities were $46.3 million at September 30, 2024, down from $48.7 million at June 30, 2024.
|
| |
•
|
On October 28, 2024, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on November 22, 2024 to stockholders of record as of November 12, 2024.
|
Third Quarter 2024 Financial Results Conference Call
Management will host a conference call to discuss the third quarter 2024 financial results today, Wednesday, October 30, 2024 at 11:30 a.m. Eastern Time. The conference call details are as follows:
|
Date:
|
Wednesday, October 30, 2024
|
|
Time:
|
11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
|
|
Dial-in:
|
1-877-407-0789 (Domestic)
1-201-689-8562 (International)
|
|
Conference ID:
|
13749004
|
|
Webcast:
|
https://viavid.webcasts.com/starthere.jsp?ei=1689949&tp_key=eea2c2882e |
For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on October 30, 2024 through 11:59 p.m. Eastern Time on November 6, 2024 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13749004.
About Natural Health Trends Corp.
Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.
Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 28, 2024 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
CONTACT:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (Hong Kong): +852-3107-0800
Tel (U.S.): 310-541-0888
investor.relations@nhtglobal.com
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
| |
|
September 30, 2024
|
|
|
December 31, 2023
|
|
| |
|
(Unaudited)
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
22,899 |
|
|
$ |
56,178 |
|
|
Marketable securities
|
|
|
23,429 |
|
|
|
— |
|
|
Inventories
|
|
|
3,684 |
|
|
|
4,293 |
|
|
Other current assets
|
|
|
3,830 |
|
|
|
3,758 |
|
|
Total current assets
|
|
|
53,842 |
|
|
|
64,229 |
|
|
Property and equipment, net
|
|
|
205 |
|
|
|
266 |
|
|
Operating lease right-of-use assets
|
|
|
2,784 |
|
|
|
3,319 |
|
|
Restricted cash
|
|
|
38 |
|
|
|
39 |
|
|
Deferred tax asset
|
|
|
307 |
|
|
|
369 |
|
|
Other assets
|
|
|
1,115 |
|
|
|
869 |
|
|
Total assets
|
|
$ |
58,291 |
|
|
$ |
69,091 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
548 |
|
|
$ |
990 |
|
|
Income taxes payable
|
|
|
5,032 |
|
|
|
3,716 |
|
|
Accrued commissions
|
|
|
2,029 |
|
|
|
2,067 |
|
|
Other accrued expenses
|
|
|
1,350 |
|
|
|
1,170 |
|
|
Deferred revenue
|
|
|
6,832 |
|
|
|
6,166 |
|
|
Amounts held in eWallets
|
|
|
3,458 |
|
|
|
3,945 |
|
|
Operating lease liabilities
|
|
|
1,191 |
|
|
|
1,146 |
|
|
Other current liabilities
|
|
|
672 |
|
|
|
784 |
|
|
Total current liabilities
|
|
|
21,112 |
|
|
|
19,984 |
|
|
Income taxes payable
|
|
|
— |
|
|
|
5,054 |
|
|
Deferred tax liability
|
|
|
135 |
|
|
|
135 |
|
|
Operating lease liabilities
|
|
|
1,739 |
|
|
|
2,318 |
|
|
Total liabilities
|
|
|
22,986 |
|
|
|
27,491 |
|
|
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
|
Preferred stock
|
|
|
— |
|
|
|
— |
|
|
Common stock
|
|
|
13 |
|
|
|
13 |
|
|
Additional paid-in capital
|
|
|
84,865 |
|
|
|
84,695 |
|
|
Accumulated deficit
|
|
|
(24,216 |
) |
|
|
(17,703 |
) |
|
Accumulated other comprehensive loss
|
|
|
(960 |
) |
|
|
(1,069 |
) |
|
Treasury stock, at cost
|
|
|
(24,397 |
) |
|
|
(24,336 |
) |
|
Total stockholders’ equity
|
|
|
35,305 |
|
|
|
41,600 |
|
|
Total liabilities and stockholders’ equity
|
|
$ |
58,291 |
|
|
$ |
69,091 |
|
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)
| |
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
| |
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
Net sales
|
|
$ |
10,691 |
|
|
$ |
10,615 |
|
|
$ |
32,117 |
|
|
$ |
32,987 |
|
|
Cost of sales
|
|
|
2,765 |
|
|
|
2,689 |
|
|
|
8,376 |
|
|
|
8,386 |
|
|
Gross profit
|
|
|
7,926 |
|
|
|
7,926 |
|
|
|
23,741 |
|
|
|
24,601 |
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commissions expense
|
|
|
4,333 |
|
|
|
4,361 |
|
|
|
13,022 |
|
|
|
13,861 |
|
|
Selling, general and administrative expenses
|
|
|
3,868 |
|
|
|
3,857 |
|
|
|
11,597 |
|
|
|
12,169 |
|
|
Total operating expenses
|
|
|
8,201 |
|
|
|
8,218 |
|
|
|
24,619 |
|
|
|
26,030 |
|
|
Loss from operations
|
|
|
(275 |
) |
|
|
(292 |
) |
|
|
(878 |
) |
|
|
(1,429 |
) |
|
Other income, net
|
|
|
441 |
|
|
|
585 |
|
|
|
1,523 |
|
|
|
1,708 |
|
|
Income before income taxes
|
|
|
166 |
|
|
|
293 |
|
|
|
645 |
|
|
|
279 |
|
|
Income tax provision
|
|
|
131 |
|
|
|
121 |
|
|
|
249 |
|
|
|
69 |
|
|
Net income
|
|
$ |
35 |
|
|
$ |
172 |
|
|
$ |
396 |
|
|
$ |
210 |
|
|
Net income per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.00 |
|
|
$ |
0.02 |
|
|
$ |
0.03 |
|
|
$ |
0.02 |
|
|
Diluted
|
|
$ |
0.00 |
|
|
$ |
0.02 |
|
|
$ |
0.03 |
|
|
$ |
0.02 |
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
11,471 |
|
|
|
11,440 |
|
|
|
11,464 |
|
|
|
11,432 |
|
|
Diluted
|
|
|
11,490 |
|
|
|
11,454 |
|
|
|
11,488 |
|
|
|
11,449 |
|
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
| |
|
Nine Months Ended September 30,
|
|
| |
|
2024
|
|
|
2023
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
396 |
|
|
$ |
210 |
|
|
Adjustments to reconcile net income to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
100 |
|
|
|
130 |
|
|
Net accretion of marketable securities
|
|
|
(350 |
) |
|
|
— |
|
|
Share-based compensation
|
|
|
109 |
|
|
|
123 |
|
|
Noncash lease expense
|
|
|
825 |
|
|
|
830 |
|
|
Deferred income taxes
|
|
|
62 |
|
|
|
(117 |
) |
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
|
Inventories
|
|
|
619 |
|
|
|
(420 |
) |
|
Other current assets
|
|
|
(110 |
) |
|
|
(425 |
) |
|
Other assets
|
|
|
(250 |
) |
|
|
(92 |
) |
|
Accounts payable
|
|
|
(441 |
) |
|
|
(141 |
) |
|
Income taxes payable
|
|
|
(3,738 |
) |
|
|
(2,923 |
) |
|
Accrued commissions
|
|
|
(34 |
) |
|
|
(315 |
) |
|
Other accrued expenses
|
|
|
179 |
|
|
|
(58 |
) |
|
Deferred revenue
|
|
|
641 |
|
|
|
674 |
|
|
Amounts held in eWallets
|
|
|
(501 |
) |
|
|
(725 |
) |
|
Operating lease liabilities
|
|
|
(851 |
) |
|
|
(812 |
) |
|
Other current liabilities
|
|
|
(111 |
) |
|
|
(148 |
) |
|
Net cash used in operating activities
|
|
|
(3,455 |
) |
|
|
(4,209 |
) |
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(37 |
) |
|
|
(32 |
) |
|
Purchases of marketable securities
|
|
|
(44,839 |
) |
|
|
— |
|
|
Proceeds from maturities of marketable securities
|
|
|
21,786 |
|
|
|
— |
|
|
Net cash used in investing activities
|
|
|
(23,090 |
) |
|
|
(32 |
) |
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Dividends paid
|
|
|
(6,909 |
) |
|
|
(6,911 |
) |
|
Net cash used in financing activities
|
|
|
(6,909 |
) |
|
|
(6,911 |
) |
|
Effect of exchange rates on cash, cash equivalents and restricted cash
|
|
|
174 |
|
|
|
(145 |
) |
|
Net decrease in cash, cash equivalents and restricted cash
|
|
|
(33,280 |
) |
|
|
(11,297 |
) |
|
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period
|
|
|
56,217 |
|
|
|
69,746 |
|
|
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period
|
|
$ |
22,937 |
|
|
$ |
58,449 |
|
|
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Right-of-use assets obtained in exchange for operating lease liabilities
|
|
$ |
191 |
|
|
$ |
115 |
|
v3.24.3
Document And Entity Information
|
Oct. 30, 2024 |
| Document Information [Line Items] |
|
| Entity, Registrant Name |
NATURAL HEALTH TRENDS CORP.
|
| Document, Type |
8-K
|
| Document, Period End Date |
Oct. 30, 2024
|
| Entity, Incorporation, State or Country Code |
DE
|
| Entity, File Number |
001-36849
|
| Entity, Tax Identification Number |
59-2705336
|
| Entity, Address, Address Line One |
Units 1205-07, 12F, Mira Place Tower A
|
| Entity, Address, Address Line Two |
132 Nathan Road
|
| Entity, Address, Address Line Three |
Tsimshatsui
|
| Entity, Address, City or Town |
Kowloon
|
| Entity, Address, Country |
HK
|
| City Area Code |
852
|
| Local Phone Number |
3107-0800
|
| Written Communications |
false
|
| Soliciting Material |
false
|
| Pre-commencement Tender Offer |
false
|
| Pre-commencement Issuer Tender Offer |
false
|
| Entity, Emerging Growth Company |
false
|
| Title of 12(b) Security |
Common Stock
|
| Trading Symbol |
NHTC
|
| Security Exchange Name |
NASDAQ
|
| Amendment Flag |
false
|
| Entity, Central Index Key |
0000912061
|
| X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
| Name: |
dei_AmendmentFlag |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
| Name: |
dei_DocumentPeriodEndDate |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:dateItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
| Name: |
dei_DocumentType |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:submissionTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
| Name: |
dei_EntityAddressAddressLine1 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 2 such as Street or Suite number
| Name: |
dei_EntityAddressAddressLine2 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 3 such as an Office Park
| Name: |
dei_EntityAddressAddressLine3 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
+ References
+ Details
| Name: |
dei_EntityAddressCityOrTown |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionISO 3166-1 alpha-2 country code.
| Name: |
dei_EntityAddressCountry |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:countryCodeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityCentralIndexKey |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:centralIndexKeyItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionIndicate if registrant meets the emerging growth company criteria. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityEmergingGrowthCompany |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
| Name: |
dei_EntityFileNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:fileNumberItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
| Name: |
dei_EntityIncorporationStateCountryCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarStateCountryItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityRegistrantName |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityTaxIdentificationNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:employerIdItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionLocal phone number for entity.
| Name: |
dei_LocalPhoneNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
| Name: |
dei_PreCommencementIssuerTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
| Name: |
dei_PreCommencementTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTitle of a 12(b) registered security. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
| Name: |
dei_Security12bTitle |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:securityTitleItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the Exchange on which a security is registered. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
| Name: |
dei_SecurityExchangeName |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarExchangeCodeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
| Name: |
dei_SolicitingMaterial |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
| Name: |
dei_TradingSymbol |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:tradingSymbolItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
| Name: |
dei_WrittenCommunications |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
Natural Health Trends (NASDAQ:NHTC)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Natural Health Trends (NASDAQ:NHTC)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
